116 related articles for article (PubMed ID: 2148540)
21. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
[TBL] [Abstract][Full Text] [Related]
22. Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine.
Nyström J; Cardell K; Björnsdottir TB; Fryden A; Hultgren C; Sällberg M
Vaccine; 2008 Nov; 26(47):5967-72. PubMed ID: 18804140
[TBL] [Abstract][Full Text] [Related]
23. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
24. Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination.
Filion LG; Saginur R; Szczerbak N
Clin Exp Immunol; 1988 Mar; 71(3):405-9. PubMed ID: 2968200
[TBL] [Abstract][Full Text] [Related]
25. [Immune response for phase I clinical trial of a hepatitis B immunogenic complex therapeutic vaccine, YIC].
Liu SA; Xu DZ; Zhang JP; Huang KL; Yao J; Xu LF; Yuan ZH; Wen YM
Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):89-92. PubMed ID: 16494774
[TBL] [Abstract][Full Text] [Related]
26. Antigen specific suppressor T cells from chronic hepatitis B virus (HBV) carriers inhibit the responsiveness to HBsAg of allogeneic high-responder lymphocytes.
Barnaba V; Levrero M; Franco A; Zaccari C; Musca A; Balsano F
J Clin Lab Immunol; 1985 Mar; 16(3):137-42. PubMed ID: 3162024
[TBL] [Abstract][Full Text] [Related]
27. Effect of cytokines on spontaneous and allergen-induced CD23 expression, sCD23 release and Ig(E,G) synthesis from peripheral blood lymphocytes.
Pfeil T; Fischer A; Bujanowski-Weber J; Luther H; Altmeyer P; König W
Immunology; 1989 Sep; 68(1):37-44. PubMed ID: 2530155
[TBL] [Abstract][Full Text] [Related]
28. Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay.
Tuaillon E; Tabaa YA; Petitjean G; Huguet MF; Pajeaux G; Fondere JM; Ponseille B; Ducos J; Blanc P; Vendrell JP
J Immunol Methods; 2006 Aug; 315(1-2):144-52. PubMed ID: 16959261
[TBL] [Abstract][Full Text] [Related]
29. Regulatory functions of T- and accessory-cells for hepatitis B surface antigen induced specific antibody production and proliferation of human peripheral blood lymphocytes, in vitro.
Hellström U; Sylvan S; Lundbergh P
J Clin Lab Immunol; 1985 Apr; 16(4):173-81. PubMed ID: 3874965
[TBL] [Abstract][Full Text] [Related]
30. Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.
Sylvan SP; Hellström UB; Lundbergh PR
Clin Exp Immunol; 1985 Nov; 62(2):288-95. PubMed ID: 3878745
[TBL] [Abstract][Full Text] [Related]
31. The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system.
Nakagawa N; Nakagawa T; Volkman DJ; Ambrus JL; Fauci AS
J Immunol; 1987 Feb; 138(3):795-801. PubMed ID: 3100616
[TBL] [Abstract][Full Text] [Related]
32. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.
Huang LM; Chiang BL; Lee CY; Lee PI; Chi WK; Chang MH
Hepatology; 1999 Mar; 29(3):954-9. PubMed ID: 10051503
[TBL] [Abstract][Full Text] [Related]
33. [Interferon-gamma (IFN) induced by purified hepatitis B surface antigen (HBSAG) in HBV vaccines].
Fei GZ
Zhonghua Yi Xue Za Zhi; 1989 May; 69(5):271-3, 18. PubMed ID: 2509004
[TBL] [Abstract][Full Text] [Related]
34. HBsAg-induced antigen-specific T and B lymphocyte responses in chronic hepatitis B virus carriers and immune individuals.
Fernan A; Cayzer CJ; Cooksley WG
Clin Exp Immunol; 1989 May; 76(2):222-6. PubMed ID: 2788046
[TBL] [Abstract][Full Text] [Related]
35. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
Frazer IH; Jones B; Dimitrakakis M; Mackay IR
Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.
Pastorelli G; Roncarolo MG; Touraine JL; Rousset F; Pene J; de Vries JE
Clin Exp Immunol; 1989 Dec; 78(3):341-7. PubMed ID: 2575470
[TBL] [Abstract][Full Text] [Related]
37. A single dose of oral DNA immunization delivered by attenuated Salmonella typhimurium down-regulates transgene expression in HBsAg transgenic mice.
Zheng BJ; Ng MH; Chan KW; Tam S; Woo PC; Ng SP; Yuen KY
Eur J Immunol; 2002 Nov; 32(11):3294-304. PubMed ID: 12555675
[TBL] [Abstract][Full Text] [Related]
38. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal determination of hepatitis B surface antigen-specific B lymphocyte frequency in healthy high responder adults after booster vaccination.
Sam MR; Shokrgozar MA; Shokri F
Intervirology; 2008; 51(2):87-95. PubMed ID: 18477849
[TBL] [Abstract][Full Text] [Related]
40. Alterations in the immune response of nonresponders to the hepatitis B vaccine.
Nowicki MJ; Tong MJ; Bohman RE
J Infect Dis; 1985 Dec; 152(6):1245-8. PubMed ID: 2933471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
